Polyclone in tie up to market bioinformatics tool

Polyclone Bioservices, a small Bangalore-based bioinformatics company providing services in genomics and drug discovery to the life science industry, has tied up with Eppendorf India to market its bioinformatics tool 'eprime'.

According to Naveen Kulkarni, CEO, Polyclone Bioservices, eprime is a polymerase chain reaction (PCR)-based product which enables researchers to design the process and analyse genomic data which is extensively used in the research and diagnostic market.

"This product has been licensed to Eppendorf India to be installed as original equipment while selling lab apparatus in the domestic and global markets," he added. Polyclone is expected to sign 50-60 licences in India this year and earn about $100,000 in revenues globally.

Kulkarni said, the application can develop a cost-effective method of retrieving a process and analysing the genomic data. The PCR industry is valued around $4.5 billion (Euro 3.4 billion) and of this over $1 billion is accounted for by real-time PCR market alone.

This market is growing over 25 per cent annually owing to its application in various areas ranging from molecular diagnostics to gene expression profiling.

The company recently secured recognition by DSIR as an R&D unit which is expected to enable the company to foray into research activities funded by the DST, DBT and various other government initiatives.